Home › Mutual Funds › Nippon India Mutual Fund › Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl
Latest NAV & returns of NIPPON INDIA PRIVATE LTD.

Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl

Add To Compare

previously known as Nippon India Pharma Dir DR until

170.662 (0.222%)
NAV on September 16, 2025
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 8,357 cr
Turnover Ratio 14.27%
Expense Ratio 0.89%
Exit Load 1.00%if redeemed within
1 Months0.00%if redeemed after 1 Months
Returns
  • 1M: -0.19%
  • 1Y: -1.24%
  • 3M: 0.64%
  • 3Y: 24.53%
  • 6M: 12.17%
  • 5Y: 21.10%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Sailesh Raj Bhan (Since over 20 years) Kinjal Desai (Since over 7 years)
ISIN INF204K01I43
Fund Family Nippon India
P/E Ratio 36.11
P/B Ratio 5.78
Launch Date January 01, 2013
Benchmark BSE Healthcare TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs BSE Healthcare TR INR

Alpha 0.15
Beta 0.92
R-Squared 95.06
Info Ratio -0.38
Tracking Err 3.63
Sortino 1.829
Sharpe 1.029
Std Dev 15.158
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.0%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 100.00%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Dividends that would otherwise be paid out to investors are instead used to purchase more units in the fund. Not as tax efficient as Growth.

View Factsheet
-


Other plans of Nippon India Pharma


Other Equity funds by Nippon India

Data Partner
Click here to visit AMC website and
read all scheme related documents Nippon India Fund